ACM Research, Inc.
ACMR Nasdaq· Special Industry Machinery, Nec
Last close · Oct 27, 2026
$51.97
KIRA · Stoqly’s AI analyst, in plain words
- ACM Research, Inc. had $901M of revenue in fiscal 2025, up 15.2% on the year before. Over five years, revenue changed +41.9% a year on average.
- Its operating margin was 12.1%, down 7.2 pts: of every 100 in sales, about 12 is left after running the business.
- ACM Research, Inc. made $94.1M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 25.3% a year.
- Free cash flow was −$66.6M in fiscal 2025, −7.4% of revenue.
- ACM Research, Inc. has $505M more cash than debt.
Market cap
$3.7B
P/E
24.7x
Revenue
$901M
Net income
$94.1M
Free cash flow
−$66.6M
Operating margin
12.1%
ACM Research, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+15.2%
Yes. Sales grew 15.2% last year.
Does it make a profit?
10.4%
Yes. It keeps 10.4% of every sale as profit.
Does profit turn into cash?
−7.4%
No. It spent more cash than it brought in.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
2 / 9
Weak. It passes 2 of 9 health tests.
How is the share priced?
24.7x
One share costs 24.7 times its yearly profit per share.
What ACM Research, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 2, 2026
- Legal name
- ACM Research, Inc.
- CIK
- 0001680062
ACM Research, Inc. · ACMR
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $260M | $389M | $558M | $782M | $901M |
| Revenue growth | 65.8% | 49.7% | 43.4% | 40.2% | 15.2% |
| Gross margin | 44.2% | 47.2% | 49.5% | 50.1% | 44.4% |
| Operating margin | 14.9% | 15.2% | 17.2% | 19.3% | 12.1% |
| Net income | $37.8M | $39.3M | $77.3M | $104M | $94.1M |
| Net margin | 14.5% | 10.1% | 13.9% | 13.2% | 10.4% |
| Diluted EPS | $0.58 | $0.59 | $1.16 | $1.53 | $1.37 |
| Cash | |||||
| Cash from operations | −$40.1M | −$62.2M | −$75.3M | $152M | −$10.3M |
| Capital expenditure | $9.2M | $91.1M | $61.9M | $82.5M | $56.3M |
| Free cash flow | −$49.2M | −$153M | −$137M | $70.0M | −$66.6M |
| FCF margin | −19.0% | −39.4% | −24.6% | 8.9% | −7.4% |
| Share buybacks | $0.0M | — | — | — | — |
| Share count change | 2.8% | −0.0% | −0.7% | 2.1% | 1.6% |
| Debt and strength | |||||
| Cash and short-term investments | $592M | $268M | $203M | $427M | $793M |
| Debt incl. finance leases | $35.0M | $77.0M | $92.1M | $183M | $288M |
| Shareholders' equity | $676M | $675M | $767M | $905M | $1.5B |
| Net debt / EBITDA | −13.6x | −3.0x | −1.1x | −1.5x | −4.1x |
| Current ratio | 4.6x | 2.4x | 2.3x | 2.3x | 3.3x |
| Interest coverage | 50.6x | 35.7x | 35.7x | 36.4x | 15.7x |
| Returns and quality | |||||
| Return on capital | 32.4% | 9.2% | 12.2% | 18.0% | 10.3% |
| Return on equity | 9.2% | 5.8% | 10.7% | 12.4% | 7.9% |
| Return on tangible equity | 5.6% | 5.8% | 10.1% | 11.5% | 6.4% |
| Piotroski F-score | 3 | 4 | 6 | 6 | 2 |
| Altman Z'' | 8.1 | 5.3 | 5.2 | 5.2 | 6.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$51.2M
8 insiders
Of sales under plans
100%
$51.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
ACM Research, Inc. · ACMR
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $51.97 a share, the company is worth $3.7B: 24.7 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001680062). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.